INSTIL BIO INC's ticker is TIL and the CUSIP is 45783C101. A total of 79 filers reported holding INSTIL BIO INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $933,093,000 | -58.6% | 201,968 | -3.8% | 0.00% | -100.0% |
Q1 2022 | $2,256,318,000 | -41.9% | 209,890 | -7.5% | 0.00% | 0.0% |
Q4 2021 | $3,881,935,000 | -6.2% | 226,881 | -2.0% | 0.00% | -50.0% |
Q3 2021 | $4,139,546,000 | -10.0% | 231,583 | -2.7% | 0.00% | 0.0% |
Q2 2021 | $4,597,367,000 | – | 237,959 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Curative Ventures V LLC | 37,980,073 | $649,839,000 | 100.00% |
CPMG Inc | 8,478,790 | $145,072,000 | 26.75% |
VR Adviser, LLC | 6,865,076 | $117,461,000 | 16.06% |
Vivo Capital, LLC | 12,486,787 | $213,649,000 | 12.88% |
Samsara BioCapital, LLC | 1,991,950 | $34,082,000 | 6.61% |
Fairmount Funds Management LLC | 673,905 | $11,531,000 | 3.80% |
RA Capital Management | 4,870,793 | $83,339,000 | 1.47% |
Parametrica Management Ltd | 50,699 | $867,000 | 0.86% |
HighVista Strategies LLC | 56,901 | $974,000 | 0.78% |
Nicholas Investment Partners, LP | 713,221 | $12,203,000 | 0.77% |